Clinical Trials Directory

Trials / Completed

CompletedNCT02422160

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.

Conditions

Interventions

TypeNameDescription
OTHERNo interventions are plannedNo interventions are planned

Timeline

Start date
2015-04-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2015-04-21
Last updated
2022-05-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02422160. Inclusion in this directory is not an endorsement.

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration (NCT02422160) · Clinical Trials Directory